Eli Lilly and Co’s drug Gemzar should be more widely used to treat advanced breast cancer following a trial in which people taking it and the standard drug paclitaxel lived months longer than those taking paclitaxel alone, a researcher said on Saturday.

Official Title


Study Type

Study Design

Further Details

Study Start

Eligibility & Criteria

Total Enrolment

Contact Details